News Releases

The following news releases are issued by GlaxoSmithKline Inc. In addition to these resources, you may also find GlaxoSmithKline global news of interest.

December 23, 2005

For fifth consecutive year, GlaxoSmithKline recognized as one of the 50 Best Employers in Canada -- For the fifth year in a row, GlaxoSmithKline Inc. (GSK) has been named one of the 50 Best Employers in Canada in the annual list published by The Globe and Mail's Report on Business Magazine.

December 08, 2005

GlaxoSmithKline Acquires Influenza Vaccine Manufacturer ID Biomedical Corporation -- Mississauga, Canada - GlaxoSmithKline plc (NYSE:GSK) today announced the completion of the acquisition of ID Biomedical.

November 15, 2005

Paul Lucas: new chaiman of RX&D'S board of directors -- Canada's Research-Based Pharmaceutical Companies (Rx&D) is pleased to announce the appointment of Paul Lucas, President and Chief Executive Officer (CEO) of GlaxoSmithKline Inc., as Chairman of the Board of Directors.

September 29, 2005

GlaxoSmithKline, with Premier Dalton McGuinty, Announces Manufacturing Expansion, Job Creation and Innovation Investment -- GlaxoSmithKline Inc. President and CEO Paul Lucas will be joined later today by The Honourable Dalton McGuinty, Premier of Ontario and Minister of Research and Innovation

September 20, 2005

Canadian Diabetes Study: A Wake-up Call -- Data from the largest diabetes study of its kind in Canada show that one in two people with type 2 diabetes does not have their blood sugar under control

September 14, 2005

New Research Chair at University of Ottawa to Advance Understanding of Neurological and Psychiatric Disorders -- Leading Health Research Organizations Partner to Fund $2 million Dr. J. David Grimes Research Chair

September 07, 2005

GlaxoSmithKline to Acquire ID Biomedical Corporation

June 03, 2005

New GSK Professorship in Inflammatory Lung Disease Established at University of Calgary -- The University of Calgary and GlaxoSmithKline Partner to Advance Vital Research in the Area of Chronic Lung Disease

June 02, 2005

New GSK Chair in Airway Inflammation Established at University of Alberta -- GlaxoSmithKline Responds to Need for Continued Research and Understanding of Respiratory Illness with $1 Million Endowment

January 26, 2005

$5 Million Respiratory Research Funding for Firestone Institute Already Breathing Success -- GlaxoSmithKline's Five-year Research Funding Commitment Helps Drive Understanding and Treatment of Respiratory Disease.

January 03, 2005

GlaxoSmithKline Named One of Canada's 50 Best Employers for Fourth Straight Year